Serve You Rx launches Biosimilar Advantage Formulary to boost biosimilar adoption and affordability.
Serve You Rx launches Biosimilar Advantage Formulary to speed up biosimilar adoption and affordability. The new strategy positions biosimilars with lower upfront costs as preferred treatments while holding reference brands as excluded or non-preferred. Despite their potential for significant cost savings, biosimilars' adoption in the U.S. has been slow, capturing only ~2% of new-to-brand prescriptions.
June 12, 2024
4 Articles